FIBRINOLYTIC AND DEFIBRINATING EFFECT OF PHENFORMIN PLUS ETHYLŒSTRENOL IN VIVO
Authors:
- G.R. FearnleyGFG.R. Fearnley
- R. ChakrabartiRCR. Chakrabarti
- J.F. EvansJEJ.F. Evans
- 1 May 1969
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 293 (7601) , 910-914
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- EFFECT OF ETHYLŒSTRENOL COMBINED WITH PHENFORMIN OR WITH METFORMIN ON PLATELET STICKINESS AND SERUM-CHOLESTEROL IN PATIENTS WITH OCCLUSIVE VASCULAR DISEASEThe Lancet, 1968
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968
- THERAPEUTIC DEFIBRINATION IN THE TREATMENT OF THROMBOTIC DISEASEThe Lancet, 1968
- FIBRINOLYTIC EFFECTS OF DIGUANIDES PLUS ETHYLŒSTRENOL IN OCCLUSIVE VASCULAR DISEASEThe Lancet, 1967
- REDUCTION OF PLATELET STICKINESS BY PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1967
- GASTRIC FIBRINOLYSIS A Possible qtiological Link with Peptic UlcerThe Lancet, 1967
- FIBRINOLYTIC TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1966
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- A CONCEPT OF NATURAL FIBRINOLYSISThe Lancet, 1961
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956